abstract |
The present invention provides a heterocyclic compound represented by the following formula (I) n nor a pharmaceutically acceptable salt thereof, in which X A , R 1 , Y A , R 2 , R 3A , and R 4A are as defined herein. The compound of formula (I) inhibits a C-C chemokine receptor type 10 (CCR10) receptor and is useful as a prophylactic and/or therapeutic agent for skin diseases. |